### Section 10: EXIT STRATEGY (`/returns`)
**Purpose:** Show investors exactly how they get their money back, and then some.

#### Return Pathways (Interactive Timeline)
```
┌─────────────────────────────────────────────────────────────────────────────┐
│                                                                             │
│                           INVESTOR RETURN PATHWAYS                          │
│                                                                             │
│   PATH 1: STRATEGIC ACQUISITION (Most Likely)          Target: Year 5-7    │
│   ──────────────────────────────────────────────────────────────────────   │
│                                                                             │
│   Potential Acquirers:                                                      │
│   • Luxury hospitality groups (Aman, Six Senses, Four Seasons)             │
│   • Healthcare systems expanding into wellness (Cleveland Clinic, Mayo)    │
│   • Private equity wellness platforms (KKR, Blackstone wellness funds)     │
│   • Longevity-focused investors (Altos Labs, Calico adjacents)             │
│                                                                             │
│   Why They'd Acquire:                                                       │
│   ✓ Category leadership in $1T+ market                                     │
│   ✓ Proven protocols and outcome data                                      │
│   ✓ Established brand and referral network                                 │
│   ✓ Platform and technology infrastructure                                 │
│   ✓ Talent team with specialized expertise                                 │
│                                                                             │
│   Comparable Exits:                                                         │
│   • Equinox sold at 15x EBITDA                                             │
│   • Miraval acquired by Hyatt for $215M (12x revenue)                      │
│   • Life Time Fitness valued at $4B+ (public)                              │
│                                                                             │
│   ────────────────────────────────────────────────────────────────         │
│                                                                             │
│   PATH 2: IPO/SPAC (Ambitious)                         Target: Year 7-10   │
│   ──────────────────────────────────────────────────────────────────────   │
│                                                                             │
│   Requirements:                                                             │
│   ✓ $50M+ annual revenue                                                   │
│   ✓ 15+ locations operational                                              │
│   ✓ Strong unit economics demonstrated                                     │
│   ✓ Category-defining brand recognition                                    │
│                                                                             │
│   ────────────────────────────────────────────────────────────────         │
│                                                                             │
│   PATH 3: DIVIDEND RECAPITALIZATION                    Target: Year 4+     │
│   ──────────────────────────────────────────────────────────────────────   │
│                                                                             │
│   At 70%+ occupancy with strong margins:                                   │
│   ✓ Annual distributions to investors                                      │
│   ✓ Partial liquidity while maintaining ownership                          │
│   ✓ Retained earnings fund expansion                                       │
│                                                                             │
│   ────────────────────────────────────────────────────────────────         │
│                                                                             │
│   PROJECTED RETURNS (Base Case)                                            │
│   ──────────────────────────────                                           │
│   Total Raise: $14,953,500                                                 │
│   5-Year IRR: 78%                                                       │
│   MOIC: 7.8x                                                              │
│   Y5 Enterprise Value: $81,200,000 (4.0x EBITDA, single location)          │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘
```

#### Comparable Transactions Analysis (Detailed)

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                                                                             │
│   WELLNESS & HOSPITALITY M&A COMPS                                         │
│                                                                             │
│   Company              Buyer           Year   Price    Revenue  Multiple   │
│   ────────────────────────────────────────────────────────────────────────│
│   LUXURY WELLNESS ACQUISITIONS                                             │
│   Miraval Resorts      Hyatt           2017   $215M    $18M     11.9x     │
│   • 3 properties, transformational wellness focus                          │
│   • EBITDA margin: ~30% → implied 40x EBITDA                               │
│   • Strategic premium: Hyatt wanted wellness vertical                      │
│   • Comp Relevance: ⭐⭐⭐⭐⭐ (closest to our model)                      │
│                                                                             │
│   Canyon Ranch         Omni Hotels     2018   Private  ~$50M    ~3-4x     │
│   • 3 locations, medical wellness pioneer                                  │
│   • Struggled financially, distressed sale                                 │
│   • Lower multiple reflects operational issues                             │
│   • Comp Relevance: ⭐⭐⭐ (cautionary tale)                              │
│                                                                             │
│   SHA Wellness         Private Equity  2021   €100M    €20M     5x        │
│   • Single flagship property in Spain                                      │
│   • 90% occupancy, strong margins                                          │
│   • Sold to expand globally                                                │
│   • Comp Relevance: ⭐⭐⭐⭐ (similar luxury positioning)                 │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│   PREMIUM FITNESS/WELLNESS PLATFORMS                                       │
│   Equinox               Various        2017   $1.8B    $1.5B    1.2x      │
│   • 100+ locations, membership model                                       │
│   • EBITDA: $120M → 15x EBITDA multiple                                    │
│   • Premium brand with loyal following                                     │
│   • Comp Relevance: ⭐⭐ (different model, but brand value lesson)        │
│                                                                             │
│   Life Time Fitness    TPG (→ IPO)    2015   $4B      $1.4B    2.9x       │
│   • 150+ locations, family-oriented                                        │
│   • Went private, then re-IPO'd in 2021                                    │
│   • Current market cap: $5.2B                                              │
│   • Comp Relevance: ⭐⭐ (scale story, different segment)                 │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│   MENTAL HEALTH & TRANSFORMATION                                           │
│   Spring Health        Various (VC)   2023   $3.3B*   $100M    33x        │
│   • Digital mental health platform                                         │
│   • *Valuation, not exit (showing investor appetite)                       │
│   • $200M ARR by 2024                                                      │
│   • Comp Relevance: ⭐⭐ (shows mental health premium)                    │
│                                                                             │
│   Headspace Health     Merger (public) 2021   $3B*     $100M+   30x       │
│   • Meditation app (Headspace + Ginger)                                    │
│   • SPAC merger, now public                                                │
│   • Shows digital health investor appetite                                 │
│   • Comp Relevance: ⭐⭐ (category creation parallels)                    │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│   BOUTIQUE HOSPITALITY (Asset-Heavy)                                       │
│   Aman Resorts         Vlad Doronin    2014   $358M    ~$200M   1.8x      │
│   • 34 ultra-luxury properties                                             │
│   • Built on exclusivity and brand                                         │
│   • Lower revenue multiple, high EBITDA multiple (~12-15x)                 │
│   • Comp Relevance: ⭐⭐⭐ (luxury brand playbook)                        │
│                                                                             │
│   Six Senses          IHG               2019   $300M    ~$80M    3.8x      │
│   • 16 wellness resorts                                                    │
│   • Sustainability + wellness positioning                                  │
│   • Strategic acquisition for portfolio expansion                          │
│   • Comp Relevance: ⭐⭐⭐⭐ (wellness-focused luxury)                    │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘
```

#### Valuation Methodology & Exit Scenarios

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                                                                             │
│   YEAR 5 EXIT VALUATION FRAMEWORK                                          │
│                                                                             │
│   Scenario 1: EBITDA Multiple Approach                                     │
│   ────────────────────────────────────────────────────────────────────────│
│   Year 5 EBITDA (Base Case):  $20.3M                                       │
│   Exit Multiple Range:         4.0x - 6.0x                                  │
│                                                                             │
│   Conservative (4.0x):         $81.2M                                      │
│   • Single location at scale, strong unit economics                        │
│   • Conservative single-location multiple during expansion phase           │
│                                                                             │
│   Base Case (4.0x + platform): $81.2M                                      │
│   • Base-case enterprise value                                             │
│   • Y5 Enterprise Value: $81.2M                                            │
│                                                                             │
│   Optimistic (6.0x):           $122.0M                                     │
│   • Expansion underway, category leadership established                    │
│   • Comparable: Equinox (15x EBITDA reflects brand premium)                │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   Scenario 2: Revenue Multiple Approach                                    │
│   ────────────────────────────────────────────────────────────────────────│
│   Year 5 Revenue (Base Case):  $34.0M                                      │
│   Exit Multiple Range:          2x - 4x                                    │
│                                                                             │
│   Conservative (2x):            $68.0M                                     │
│   • Industry standard for boutique wellness/hospitality                    │
│   • Comparable: Life Time (2.9x), Equinox (1.2x but EBITDA heavy)          │
│                                                                             │
│   Base Case (2.4x):             $81.2M                                     │
│   • Aligns with EBITDA-method base case                                    │
│   • Comparable: Six Senses (3.8x), SHA (5x)                                │
│                                                                             │
│   Optimistic (3.6x):            $122.0M                                    │
│   • Strategic premium if bidding war or platform potential                 │
│   • Comparable: Miraval (11.9x shows strategic can pay up)                 │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   Return Profile Summary                                                   │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   Y5 Enterprise Value (Base):   $81,200,000                                │
│   5-Year Revenue:               $120,700,000                               │
│   5-Year Net Income:            $45,102,667                                │
│   Y5 EBITDA:                    $20,299,217                                │
│   ──────────────────────────────────────                                   │
│                                                                             │
│   Investor Returns (Seed Round):                                           │
│   Total Raise: $14,953,500                                                 │
│   ──────────────────────────────────────                                   │
│   MOIC: 7.8x (base case)                                                  │
│   IRR: 78% (5-year hold, base case)                                     │
│   Conservative: 66% IRR / 5.5x MOIC                                       │
│   Aggressive: 87% IRR / 10.0x MOIC                                        │
│                                                                             │
│   Note: Base case assumptions. Series A dilution would reduce ownership    │
│   but increase absolute value through growth acceleration.                 │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘
```

#### Specific Acquirer Profiles

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                                                                             │
│   TOP 5 MOST LIKELY ACQUIRERS                                              │
│                                                                             │
│   1. HYATT (Most Likely)                               Probability: 30%    │
│   ────────────────────────────────────────────────────────────────────────│
│   Why They'd Buy:                                                          │
│   • Already own Miraval (transformational wellness)                        │
│   • Expanding wellness vertical aggressively                               │
│   • Want global footprint in transformation space                          │
│   • Our 30-location plan fits their growth strategy                        │
│                                                                             │
│   What They'd Pay:                                                         │
│   • Strategic premium (6-8x EBITDA)                                        │
│   • $50-70M for proven concept + expansion rights                          │
│   • Likely buyer in Year 5-7                                               │
│                                                                             │
│   Relationship Building:                                                   │
│   • Introduce Year 2 (too early Year 1)                                    │
│   • Invite Miraval leadership to visit as guests                           │
│   • Explore partnership on outcomes research                               │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   2. ACCOR (Luxury Division)                           Probability: 20%    │
│   ────────────────────────────────────────────────────────────────────────│
│   Why They'd Buy:                                                          │
│   • Own Rixos, Raffles, Fairmont (luxury brands)                           │
│   • Looking to differentiate in wellness space                             │
│   • Strong presence in Mexico, Europe (our expansion markets)              │
│   • No transformational offering in portfolio                              │
│                                                                             │
│   What They'd Pay:                                                         │
│   • Portfolio expansion multiple (5-7x EBITDA)                             │
│   • $45-60M range                                                          │
│   • Likely buyer in Year 6-8                                               │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   3. KKR / BLACKSTONE (PE Wellness Roll-Up)            Probability: 25%    │
│   ────────────────────────────────────────────────────────────────────────│
│   Why They'd Buy:                                                          │
│   • Building wellness platforms (roll-up strategy)                         │
│   • See $1T market opportunity                                             │
│   • Want category-defining brands to anchor portfolio                      │
│   • Can fund aggressive expansion                                          │
│                                                                             │
│   What They'd Pay:                                                         │
│   • Platform premium (7-10x EBITDA)                                        │
│   • $60-80M+ if we're clear category leader                                │
│   • Likely buyer in Year 5-6 (earlier than strategic)                      │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   4. COMPASS PATHWAYS / ATAI LIFE SCIENCES (Psychedelic) Probability: 15% │
│   ────────────────────────────────────────────────────────────────────────│
│   Why They'd Buy:                                                          │
│   • Need real-world delivery infrastructure for therapies                  │
│   • We have medical protocols + outcome data                               │
│   • Vertical integration play (research → treatment delivery)              │
│   • Our model de-risks their regulatory pathway                            │
│                                                                             │
│   What They'd Pay:                                                         │
│   • Depends on their market cap + FDA approval timeline                    │
│   • Likely acqui-hire + infrastructure (lower multiple)                    │
│   • $30-50M range                                                          │
│   • Timing: Year 6-10 (when psychedelic therapy is approved)               │
│                                                                             │
│   ────────────────────────────────────────────────────────────────────────│
│                                                                             │
│   5. SOVEREIGN WEALTH FUND (UAE, Saudi)                Probability: 10%    │
│   ────────────────────────────────────────────────────────────────────────│
│   Why They'd Buy:                                                          │
│   • Diversifying into wellness/longevity                                   │
│   • Saudi Vision 2030, UAE wellness tourism push                           │
│   • Want Western brands to legitimize their markets                        │
│   • Deep pockets, patient capital                                          │
│                                                                             │
│   What They'd Pay:                                                         │
│   • Trophy asset premium (8-12x EBITDA)                                    │
│   • $70-100M+ (can overpay strategically)                                  │
│   • Likely buyer in Year 7-10 (want proven global brand)                   │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘
```

#### Exit Preparation Roadmap

```
┌─────────────────────────────────────────────────────────────────────────────┐
│                                                                             │
│   BUILDING FOR EXIT FROM DAY 1                                             │
│                                                                             │
│   Year 1-2: Foundation                                                     │
│   • Clean cap table (no messy structures)                                  │
│   • Audited financials from inception (Big 4 preferred)                    │
│   • Board minutes meticulously documented                                  │
│   • All contracts in writing (no handshake deals)                          │
│   • IP properly assigned to company                                        │
│                                                                             │
│   Year 3-4: Optimization                                                   │
│   • Unit economics proven and documented                                   │
│   • Outcome data published (credibility)                                   │
│   • Key talent locked in (reduce key person risk)                          │
│   • Expansion playbook documented (proves scalability)                     │
│   • Strategic relationships cultivated (potential buyers)                  │
│                                                                             │
│   Year 5: Pre-Exit                                                         │
│   • Hire investment bank (Moelis, Jefferies, Guggenheim)                   │
│   • Prepare CIM (Confidential Information Memorandum)                      │
│   • Management presentations polished                                      │
│   • Data room organized (due diligence ready)                              │
│   • Quality of earnings study (financial validation)                       │
│   • "Quiet" outreach to strategic buyers                                   │
│                                                                             │
│   Year 5-7: Exit Execution                                                 │
│   • Dual-track process (strategic + PE)                                    │
│   • Competitive tension (3-5 serious bidders)                              │
│   • LOI negotiation                                                        │
│   • Due diligence (90-120 days)                                            │
│   • Definitive agreement                                                   │
│   • Close (6-9 months from LOI to wire)                                    │
│                                                                             │
│   Success Factors:                                                         │
│   ✓ Multiple bidders (creates pricing tension)                             │
│   ✓ Clean story (no surprises in due diligence)                            │
│   ✓ Founder staying post-close (de-risks transition)                       │
│   ✓ Growth trajectory visible (not just current state)                     │
│   ✓ Strategic rationale clear (why WE'RE the answer to THEIR problem)      │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘
```

---

